New Documentary The Power of Intention with Lynne McTaggart Free Worldwide Online Premiere
Join a Global Movement of People Using the Universe’s Most Powerful Tool – Collective Intention – to Transform Your Life, […]
Eos Energy Secures 400 MWh Order with International Electric Power to Deliver Critical Resilience in California
EDISON, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), America’s leading […]
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of Testing […]
Worksport Ltd. ($WKSP) Shares Enhanced Strategic Vision & Opportunity on New and Improved Investor Relations Website
“Worksport’s Road to a $13B Target Market” Underscores the Company’s Growth Strategy, Clean-Tech Innovations, and Expanding Operations West Seneca, New […]
HBT Financial, Inc. Announces Authorization of New $15 Million Stock Repurchase Program
BLOOMINGTON, Ill., Dec. 18, 2024 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”) announced today […]
500 LEVEL Poised for Breakthrough Growth in Professional Sports Apparel with Kornit Digital’s On-Demand Solutions
Leading the charge in the dynamic e-commerce market, 500 LEVEL is delivering premium-quality MLB, MLS, NBA, NFL, NHL, UFC and […]
Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Septerna, a clinical-stage biotechnology company pioneering a new era of […]
Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome
Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the […]
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trial Monotherapy activity with […]
Daxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales Momentum
Healthcare Providers Embrace Blood Volume Analysis (BVA) in Nephrology and Heart Failure Outpatient Care Oak Ridge, TN, Dec. 18, 2024 […]
